Launch of Melanoma March 2021
1 March 2021
Not-for-profit organisation Melanoma Institute Australia (MIA) is calling on all Australians to join its innovative new Melanoma March campaign to raise awareness and funds to combat one of Australia’s biggest killers.
This year is the 10th anniversary of its national Melanoma March campaign. Due to COVID, the traditional family-friendly physical events have been replaced with an interactive digital campaign that all Australians can step up and take part in.
Everyone is asked to buy a $30 digital footprint in support of the one Aussie every 30 minutes who is told they have melanoma. Each footprint is then personalised with a message of support or hope, and shared to socials to spread the word.
Throughout the month of March, Melanoma Institute Australia wants to progressively cover its map of Australia with digital footprints, and in the process raise $500,000 for lifesaving research to develop new treatments for melanoma.
The interactive digital campaign goes live on Monday 1st March. To buy a digital footprint and see Australia be progressively covered in footprints, go to melanomamarch.org.au
Here's a short video to explain how it works:
Melanoma Institute Australia CEO Matthew Browne said just as melanoma can impact anyone - regardless of gender, age, skin type or where you live - anyone can take part in this year’s innovative digital Melanoma March campaign.
‘Melanoma is Australia’s national cancer, and no matter what part of this vast country we live in, we all have a responsibility to leave our footprint on melanoma and help save lives from this disease,’ Mr Browne said.
‘We want all Aussies to buy, personalise and share a digital footprint to support our ongoing research effort so we can reach our ultimate goal of zero deaths from melanoma.’
Australia has the highest melanoma rates in the world with one person diagnosed with the disease every 30 minutes. It is estimated 1300 people will die from melanoma in Australia this year. Melanoma is also the most common cancer affecting 15 to 39 year old Australians.
Melanoma March is an initiative of Melanoma Institute Australia, incorporating melanomaWA and Amie St Clair.
It is proudly supported by Melanoma Patients Australia, Australian Melanoma Research Foundation, Skin Cancer Tasmania and other melanoma research organisations across Australia.
For media enquiries, please contact:
Jennifer Durante |Melanoma Institute Australia | 0412 798 990 | firstname.lastname@example.org
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.